These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Ocqueteau M, Orfao A, Almeida J, Bladé J, González M, García-Sanz R, López-Berges C, Moro MJ, Hernández J, Escribano L, Caballero D, Rozman M, San Miguel JF. Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070 [Abstract] [Full Text] [Related]
3. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance. Almeida J, Orfao A, Mateo G, Ocqueteau M, García-Sanz R, Moro MJ, Hernandez J, Ortega F, Borrego D, Barez A, Mejido M, San Miguel JF. Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879 [Abstract] [Full Text] [Related]
11. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S. Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287 [Abstract] [Full Text] [Related]
13. Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation. Hillengass J, Zechmann C, Bäuerle T, Wagner-Gund B, Heiss C, Benner A, Ho A, Neben K, Hose D, Kauczor HU, Goldschmidt H, Delorme S, Moehler T. Clin Cancer Res; 2009 May 01; 15(9):3118-25. PubMed ID: 19366830 [Abstract] [Full Text] [Related]
15. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders. Raja KR, Kovarova L, Hajek R. Br J Haematol; 2010 May 01; 149(3):334-51. PubMed ID: 20201947 [Abstract] [Full Text] [Related]
16. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients. Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M. Leuk Res; 2010 Jan 01; 34(1):38-45. PubMed ID: 19596432 [Abstract] [Full Text] [Related]
20. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells. Pérez-Persona E, Mateo G, García-Sanz R, Mateos MV, de Las Heras N, de Coca AG, Hernández JM, Galende J, Martín-Nuñez G, Bárez A, Alonso JM, Martín A, López-Berges C, Orfao A, San Miguel JF, Vidriales MB. Br J Haematol; 2010 Jan 01; 148(1):110-4. PubMed ID: 19821821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]